Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant—A Prospective Phase II Study

In this prospective phase II clinical trial, multiple myeloma (MM) patients were randomized to receive a second (tandem) autologous stem cell transplantation (ASCT) based on whether they achieved a partial response or worse (≤PR) following initial ASCT (ASCT1). Patients who achieved a very good part...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Michael Byrne, Donya Salmasinia, Helen Leather, Christopher R. Cogle, Amy Davis, Jack W. Hsu, Laura Wiggins, Myron N. Chang, Qi An, John R. Wingard, Jan S. Moreb
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SAGE Publishing 2014-01-01
coleção:	Clinical Medicine Insights: Oncology
Acesso em linha:	https://doi.org/10.4137/CMO.S16835
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!